- •Despite guidelines, many health care providers are not routinely recommending HPV vaccine for 11- to 12-year-old girls or boys.
- •Health care providers perceive parental HPV vaccine hesitancy to be common.
- •Perceptions of hesitancy may discourage providers from routinely recommending HPV vaccine.
- •Providers' self-efficacy to address hesitancy may be important for improving vaccine uptake.
- •Findings highlight potential tools for more effectively counseling vaccine-hesitant parents.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric Health Care
- Parental decision making about the HPV vaccine.Cancer Epidemiology, Biomarkers and Prevention. 2010; 19: 2187-2198
- HPV vaccination of boys in primary care practices.Academic Pediatrics. 2013; 13: 466-474
- Standard definitions: Final dispositions of case codes and outcome rates for surveys.6th ed. Author, Deerfield, IL2009
- Social foundations of thought and action.Prentice Hall, Englewood Cliffs, NJ1986
- Why don’t physicians follow clinical practice guidelines?.Journal of the American Medical Association. 1999; 282: 1458-1465
- FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).Morbidity and Mortality Weekly Report. 2010; 59: 630-632
- National and state vaccination coverage among adolescents aged 13–17 years—United States, 2012.Morbidity and Mortality Weekly Report. 2013; 62: 685-693
- Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure.Pediatrics. 2010; 126: 425-433
- Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008–2010.Pediatrics. 2013; 131: 645-651
- Understanding the reasons why mothers do or do not have their adolescent daughter vaccinated against human papillomavirus.Annals of Epidemiology. 2009; 19: 531-538
- Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.Pediatrics. 2006; 117: 1486-1493
- Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey—Teen, 2009.Clinical Pediatrics. 2011; 50: 1116-1124
- Recommendations on the use of quadrivalent human papillomavirus vaccine in males— Advisory Committee on Immunization Practices (ACIP).Morbity and Mortality Weekly Report. 2011; 60: 1705-1708
- Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt.Pediatrics. 2013; 131: 1114-1124
- Forgone vaccination during childhood and adolescence: Findings of a statewide survey of parents.Preventive Medicine. 2013; 56: 202-306
- Do correlates of HPV vaccine initiation differ between adolescent boys and girls?.Vaccine. 2012; 30: 5928-5934
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support.Journal of Biomedical Informatics. 2009; 42: 377-381
- Parent and provider perspectives on immunization: Are providers overestimating parental concerns?.Vaccine. 2014; 32: 579-584
- HPV vaccine decision making in pediatric primary care: A semi-structured interview study.BMC Pediatrics. 2011; 11: 74
- Pediatricians’ intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudes.Journal of Adolescent Health. 2005; 37: 502-510
- Prevalence of parental concerns about childhood vaccines: The experience of primary care physicians.American Journal of Preventive Medicine. 2011; 40: 548-555
- Tailored and targeted health communication: Strategies for enhancing information relevance.American Journal of Health Behavior. 2003; 27: S227-S232
- Perceived need of a parental decision aid for the HPV vaccine: Content and format preferences.Health Promotion Practice. 2012; 13: 214-221
- Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).Morbity and Mortality Weekly Report. 2007; 56: 1-24
- Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study.Vaccine. 2012; 30: 1269-1275
- Validity and reliability of a survey to identify vaccine-hesitant parents.Vaccine. 2011; 29: 6598-6605
- Providers’ perceptions of parental concerns about HPV vaccination.Journal of Health Care for the Poor and Underserved. 2013; 24: 828-839
- Parents’ health beliefs and HPV vaccination of their adolescent daughters.Social Science and Medicine. 2009; 69: 475-480
- HPV vaccination among adolescent males: Results from the National Immunization Survey-Teen.Vaccine. 2013; 31: 2816-2821
- Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate.Vaccine. 2013; 31: 3121-3125
- Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician’s recommendation.Vaccine. 2011; 29: 890-895
- A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy.Vaccine. 2013; 31: 4293-4304
U.S. Department of Health and Human Services. (2014). Healthy People 2020 objectives: Immunization and infectious diseases. Retrieved from http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=23
- Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited.Vaccine. 2011; 29: 8634-8641
- Human papillomavirus vaccination of males: Attitudes and perceptions of physicians who vaccinate females.Journal of Adolescent Health. 2010; 47: 3-11
- Cognitive interviewing: A tool for improving questionnaire design.Sage Publications, Thousand Oaks, CA2005
- Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US national immunization survey.American Journal of Public Health. 2013; 103: 164-169
This study was funded through a Young Investigator Award from the Academic Pediatric Association, supported by the Maternal and Child Health Bureau in partnership with the American Academy of Pediatrics (U04MC07853-03; primary investigator [PI], McRee) with further support from a National Research Service Award in Primary Medical Care from the Health Resources and Services Administration (T32HP22239; PI, Borowsky); the University of North Carolina Lineberger Cancer Control Education Program (R25 CA57726); and a Clinical and Translational Science Institute grant support (UL1RR033183) to the University of Minnesota from the National Center for Research Resources.
Conflicts of interest: ALM and MBG have no conflicts of interest to disclose. AFD serves on an advisory board for Merck, a company that manufactures human papillomavirus vaccine, although she does not receive research funding from this company.